Tonix Pharmaceuticals Holding Corp (TNXP)
0.1412
0.00 (0.00%)
USD |
NASDAQ |
Nov 07, 16:00
0.137
0.00 (0.00%)
After-Hours: 20:00
Tonix Pharmaceuticals Revenue (TTM): 12.46M for June 30, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| June 30, 2024 | 12.46M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
12.46M
Minimum
Jun 2024
12.46M
Maximum
Jun 2024
12.46M
Average
12.46M
Median
Jun 2024
Revenue (TTM) Benchmarks
| Emergent BioSolutions Inc | 1.074B |
| Geovax Labs Inc | -- |
| Abbott Laboratories | 41.22B |
| SIGA Technologies Inc | 172.96M |
| Chimerix Inc | -- |